- call +1-201-465-4211
- email sales@mrinsights.biz
Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.
Scope of the Report:
This report focuses on the Pediatric Drugs and Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Pediatric Drugs and Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Shire Pharmaceuticals Group Plc. (UK)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Market Segment by Applications, can be divided into
Newborn
Infant
Child
There are 15 Chapters to deeply display the global Pediatric Drugs and Vaccines market.
Chapter 1, to describe Pediatric Drugs and Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pediatric Drugs and Vaccines, with sales, revenue, and price of Pediatric Drugs and Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pediatric Drugs and Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Pediatric Drugs and Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Pediatric Drugs and Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Pediatric Drugs and Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Diphtheria
1.2.2 Influenza
1.2.3 Hepatitis
1.2.4 Pneumococcal Diseases
1.2.5 Meningococcal Diseases
1.2.6 Mumps
1.2.7 Others
1.3 Market Analysis by Applications
1.3.1 Newborn
1.3.2 Infant
1.3.3 Child
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck & Co., Inc. (USA)
2.1.1 Business Overview
2.1.2 Pediatric Drugs and Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott Laboratories (USA)
2.2.1 Business Overview
2.2.2 Pediatric Drugs and Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Amgen, Inc. (USA)
2.3.1 Business Overview
2.3.2 Pediatric Drugs and Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly and Company (USA)
2.4.1 Business Overview
2.4.2 Pediatric Drugs and Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 F. Hoffmann-La Roche Ltd (Switzerland)
2.5.1 Business Overview
2.5.2 Pediatric Drugs and Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Genentech, Inc. (USA)
2.6.1 Business Overview
2.6.2 Pediatric Drugs and Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 GlaxoSmithKline plc. (UK)
2.7.1 Business Overview
2.7.2 Pediatric Drugs and Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Janssen Biologics B.V. (USA)
2.8.1 Business Overview
2.8.2 Pediatric Drugs and Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Actelion Pharmaceuticals
2.9.1 Business Overview
2.9.2 Pediatric Drugs and Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AstraZeneca Plc. (UK)
2.10.1 Business Overview
2.10.2 Pediatric Drugs and Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Boehringer Ingelheim GmbH (Germany)
2.11.1 Business Overview
2.11.2 Pediatric Drugs and Vaccines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Bristol-Myers Squibb Company (USA)
2.12.1 Business Overview
2.12.2 Pediatric Drugs and Vaccines Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Allergan, Inc. (USA)
2.13.1 Business Overview
2.13.2 Pediatric Drugs and Vaccines Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Novartis AG (Switzerland)
2.14.1 Business Overview
2.14.2 Pediatric Drugs and Vaccines Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Novo Nordisk A/S (Denmark)
2.15.1 Business Overview
2.15.2 Pediatric Drugs and Vaccines Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Pfizer, Inc. (USA)
2.16.1 Business Overview
2.16.2 Pediatric Drugs and Vaccines Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Sanofi S.A (France)
2.17.1 Business Overview
2.17.2 Pediatric Drugs and Vaccines Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Shionogi Inc. (USA)
2.18.1 Business Overview
2.18.2 Pediatric Drugs and Vaccines Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Shire Pharmaceuticals Group Plc. (UK)
2.19.1 Business Overview
2.19.2 Pediatric Drugs and Vaccines Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Shire Pharmaceuticals Group Plc. (UK) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Pediatric Drugs and Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Pediatric Drugs and Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Pediatric Drugs and Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Pediatric Drugs and Vaccines Manufacturer Market Share in 2017
3.3.2 Top 6 Pediatric Drugs and Vaccines Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Pediatric Drugs and Vaccines Market Analysis by Regions
4.1 Global Pediatric Drugs and Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Pediatric Drugs and Vaccines Sales and Market Share by Regions (2013-2018)
4.1.2 Global Pediatric Drugs and Vaccines Revenue and Market Share by Regions (2013-2018)
4.2 North America Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
4.3 Europe Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
4.5 South America Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
5 North America Pediatric Drugs and Vaccines by Countries
5.1 North America Pediatric Drugs and Vaccines Sales, Revenue and Market Share by Countries
5.1.1 North America Pediatric Drugs and Vaccines Sales and Market Share by Countries (2013-2018)
5.1.2 North America Pediatric Drugs and Vaccines Revenue and Market Share by Countries (2013-2018)
5.2 United States Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
5.3 Canada Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
5.4 Mexico Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
6 Europe Pediatric Drugs and Vaccines by Countries
6.1 Europe Pediatric Drugs and Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Europe Pediatric Drugs and Vaccines Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Pediatric Drugs and Vaccines Revenue and Market Share by Countries (2013-2018)
6.2 Germany Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
6.3 UK Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
6.4 France Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
6.5 Russia Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
6.6 Italy Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
7 Asia-Pacific Pediatric Drugs and Vaccines by Countries
7.1 Asia-Pacific Pediatric Drugs and Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Pediatric Drugs and Vaccines Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Pediatric Drugs and Vaccines Revenue and Market Share by Countries (2013-2018)
7.2 China Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
7.3 Japan Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
7.4 Korea Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
7.5 India Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
8 South America Pediatric Drugs and Vaccines by Countries
8.1 South America Pediatric Drugs and Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America Pediatric Drugs and Vaccines Sales and Market Share by Countries (2013-2018)
8.1.2 South America Pediatric Drugs and Vaccines Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
8.3 Argentina Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
8.4 Colombia Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
9 Middle East and Africa Pediatric Drugs and Vaccines by Countries
9.1 Middle East and Africa Pediatric Drugs and Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Pediatric Drugs and Vaccines Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
9.3 UAE Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
9.4 Egypt Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
9.5 Nigeria Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
9.6 South Africa Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2018)
10 Global Pediatric Drugs and Vaccines Market Segment by Type
10.1 Global Pediatric Drugs and Vaccines Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Pediatric Drugs and Vaccines Sales and Market Share by Type (2013-2018)
10.1.2 Global Pediatric Drugs and Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Diphtheria Sales Growth and Price
10.2.1 Global Diphtheria Sales Growth (2013-2018)
10.2.2 Global Diphtheria Price (2013-2018)
10.3 Influenza Sales Growth and Price
10.3.1 Global Influenza Sales Growth (2013-2018)
10.3.2 Global Influenza Price (2013-2018)
10.4 Hepatitis Sales Growth and Price
10.4.1 Global Hepatitis Sales Growth (2013-2018)
10.4.2 Global Hepatitis Price (2013-2018)
10.5 Pneumococcal Diseases Sales Growth and Price
10.5.1 Global Pneumococcal Diseases Sales Growth (2013-2018)
10.5.2 Global Pneumococcal Diseases Price (2013-2018)
10.6 Meningococcal Diseases Sales Growth and Price
10.6.1 Global Meningococcal Diseases Sales Growth (2013-2018)
10.6.2 Global Meningococcal Diseases Price (2013-2018)
10.7 Mumps Sales Growth and Price
10.7.1 Global Mumps Sales Growth (2013-2018)
10.7.2 Global Mumps Price (2013-2018)
10.8 Others Sales Growth and Price
10.8.1 Global Others Sales Growth (2013-2018)
10.8.2 Global Others Price (2013-2018)
11 Global Pediatric Drugs and Vaccines Market Segment by Application
11.1 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2013-2018)
11.2 Newborn Sales Growth (2013-2018)
11.3 Infant Sales Growth (2013-2018)
11.4 Child Sales Growth (2013-2018)
12 Pediatric Drugs and Vaccines Market Forecast (2018-2023)
12.1 Global Pediatric Drugs and Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 Pediatric Drugs and Vaccines Market Forecast by Regions (2018-2023)
12.2.1 North America Pediatric Drugs and Vaccines Market Forecast (2018-2023)
12.2.2 Europe Pediatric Drugs and Vaccines Market Forecast (2018-2023)
12.2.3 Asia-Pacific Pediatric Drugs and Vaccines Market Forecast (2018-2023)
12.2.4 South America Pediatric Drugs and Vaccines Market Forecast (2018-2023)
12.2.5 Middle East and Africa Pediatric Drugs and Vaccines Market Forecast (2018-2023)
12.3 Pediatric Drugs and Vaccines Market Forecast by Type (2018-2023)
12.3.1 Global Pediatric Drugs and Vaccines Sales Forecast by Type (2018-2023)
12.3.2 Global Pediatric Drugs and Vaccines Market Share Forecast by Type (2018-2023)
12.4 Pediatric Drugs and Vaccines Market Forecast by Application (2018-2023)
12.4.1 Global Pediatric Drugs and Vaccines Sales Forecast by Application (2018-2023)
12.4.2 Global Pediatric Drugs and Vaccines Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Pediatric Drugs and Vaccines Picture
Table Product Specifications of Pediatric Drugs and Vaccines
Figure Global Sales Market Share of Pediatric Drugs and Vaccines by
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
